Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Doximity (DOCS) to $70 from $81 and keeps an Outperform rating on the shares. The company reported a “strong” Q2, but pull-forward tempers second half growth, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Balanced Outlook on Doximity: Strong Performance Meets Conservative Guidance
- Doximity Reports Strong Q2 Growth and AI Expansion
- Closing Bell Movers: Expedia up 15%, Affirm up 12% on earnings beats
- Doximity’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Doximity raises FY26 revenue view to $640M-$646M from $628M-$636M